Avant Bio portfolio

Avant Bio has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months.

Website: avant.bio.

Type: Venture capital.

Portfolio on Recent Funding: 1.

Deals, last 12 months: 1.

Rounds led: 1 of 1.

Latest deal: Abbelight · Jan 8, 2026.

About this page

It is a venture capital firm based in New York, US, founded in 2023. Its most recent investment on record is Abbelight's Series B+ round in January 2026, which it led. That company is in Health and bio.

About Avant Bio

Firm type: Venture capital.

Headquarters: New York, US.

Founded: 2023.

Stages: Seed, Series A, Series B, Growth.

Sectors: AI & Machine Learning, Biotech, Deep Tech, Digital Health, Healthtech, Medical Devices.

Leads rounds: Yes.

Portfolio companies: 7.

Exits: 0.

Rounds led: 1.

What Avant Bio invests in

Health and bio · 1 · 100%

How Avant Bio invests

Stage	Deals	Capital in rounds
Series B+	1 100%	undisclosed

Avant Bio portfolio companies

AAbbelightSeries B+ · Jan 2026

Company	Round with Avant Bio	Total raised	Latest raise
AAbbelight Health and bio	Jan 8, 2026 Series B+ · lead	undisclosed	Jan 8, 2026 Series B+

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-09, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 1 round on Recent Funding that name Avant Bio. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Avant Bio, which is a subset of its real portfolio. API: /api/v1/investors/avant-bio (get a free API key). More: the most active VC firms and new venture capital funds.